GlaxoSmithKline to Market Non-Profit Meningitis Vaccine in Africa

Europe’s biggest drug company has announced it is taking the first steps towards marketing a vaccine in Africa from which it never expects to make money. GlaxoSmithKline says it has begun filing documents with the regulatory authorities concerning its meningitis vaccine called Globorix

Share this Story
Load More Related Articles
Load More By Red Wolf
Load More In Business

Leave a Reply

Your email address will not be published. Required fields are marked *

Photos from Flickr